Literature DB >> 11517426

Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from 3 health plans.

J Nordin1, J Mullooly, S Poblete, R Strikas, R Petrucci, F Wei, B Rush, B Safirstein, D Wheeler, K L Nichol.   

Abstract

This study developed methods and determined the impact of influenza vaccination on elderly persons in 3 large health plans: Kaiser Permanente Northwest, HealthPartners, and Oxford Health Plans. Data for the 1996-1997 and 1997-1998 seasons were extracted from administrative databases. Subjects were health plan members > or = 65 years old. Comorbid conditions collected from the preceding year were used for risk adjustment with logistic regression. The virus-vaccine match was excellent for year 1 and fair for year 2. Both years, during peak and total periods, vaccination reduced all causes of death and hospitalization for pneumonia and influenza: hospitalizations were reduced by 19%-20% and 18%-24% for years 1 and 2, respectively, and deaths were reduced by 60%-61% and 35%-39% for the same periods. These results show that all elderly persons should be immunized annually for influenza. The methods used in this study are an efficient cost-effective way to study vaccine impact and similar questions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11517426     DOI: 10.1086/323085

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  75 in total

1.  Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population.

Authors:  Adrian J Reber; Tatiana Chirkova; Jin Hyang Kim; Weiping Cao; Renata Biber; David K Shay; Suryaprakash Sambhara
Journal:  Aging Dis       Date:  2011-09-30       Impact factor: 6.745

2.  Effects of aging on the adaptive immune response to respiratory virus infections.

Authors:  Ross B Fulton; Steven M Varga
Journal:  Aging health       Date:  2009-12-01

3.  New CDC recommendations: annual influenza vaccination recommended for individuals with spinal cord injuries.

Authors:  Barry Goldstein; Frances M Weaver; Margaret C Hammond
Journal:  J Spinal Cord Med       Date:  2005       Impact factor: 1.985

4.  Racial similarities in response to standardized offer of influenza vaccination. A MetroNet study.

Authors:  Kendra L Schwartz; Anne Victoria Neale; Justin Northrup; Joseph Monsur; Divya A Patel; Rodrigo Tobar; Pascale M Wortley
Journal:  J Gen Intern Med       Date:  2006-04       Impact factor: 5.128

5.  The novel parainfluenza virus hemagglutinin-neuraminidase inhibitor BCX 2798 prevents lethal synergism between a paramyxovirus and Streptococcus pneumoniae.

Authors:  Irina V Alymova; Allen Portner; Toru Takimoto; Kelli L Boyd; Y Sudhakara Babu; Jonathan A McCullers
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

6.  Morbidity and mortality associated with influenza exposure in long-term care facilities for dependent elderly people.

Authors:  J Gaillat; C Chidiac; F Fagnani; M Pecking; M Salom; P Veyssier; F Carrat
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-05-12       Impact factor: 3.267

7.  Development and testing of a vaccination message targeted to persons with spinal cord injuries and disorders.

Authors:  Sherri L LaVela; Kenzie A Cameron; Michael Priebe; Frances M Weaver
Journal:  J Spinal Cord Med       Date:  2008       Impact factor: 1.985

Review 8.  Intranasal cold-adapted influenza virus vaccine combined with inactivated influenza virus vaccines: an extra boost for the elderly?

Authors:  Paul V Targonski; Gregory A Poland
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

9.  The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application.

Authors:  Jennifer L Lund; David B Richardson; Til Stürmer
Journal:  Curr Epidemiol Rep       Date:  2015-09-30

Review 10.  Influenza infection and COPD.

Authors:  Patrick Mallia; Sebastian L Johnston
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.